Call our freephone helpline to find out about medical negligence   1-800 989 988

Scally Report Imminent as Reports US Lab are Ending Irish Contract in Face of Wrong Diagnosis Compensation Payments

A report in the most recent edition of The Sunday Business Post has revealed that the US providers of cervical test screening in Ireland may not be renewing their contract to provide the service.

The US laboratories in question have said that they will no renew the service as they are unable to come to an agreement with the State over who accepts liability for the existing cervical test compensation claims that are in process in the judicial systems.

This new comes as Minister for Health Simon Harris is about to meet with Dr Scally ahead of the publication of his finding in the Cervical Check scandal. The report is due to be published for public consumption later this week. Minister Harris has said that he is determined that those women and families affected by the missed cervical cancer diagnoses will be officially briefed on the findings before they are released to the general public.

Update September 12 6.00pm

The Scally Report in the Cervical Check controversy which was published today has delivered a conclusion that the wrongful diagnoses came about due to a system-wide failure. In a comment made for the Minister for Health Simon Harris at the beginning of his report, Dr Gabriel Scally, stated that it seemed as though the system in place “was doomed to fail at some point”. The Scally report said that were are major weaknesses evident in the way that the screening services were being managed.

October signals the end of the existing contract for Cervical Check and under the current terms and conditions the US laboratories accept liability for any wrongful diagnosis negligence costs that are owed/will be owed under the current scheme in place. The company is now requesting that the Irish exchequer underwrite those costs. However this is something that the HSE fears would see the service cease to eixst due to the debilitating costs.

 

 

Read More